Dimebon Trials

Contributed by: Dennis Fortier, President, Medical Care Corporation
________________________________________________

New potential treatments for Alzheimer's disease and the progress of their FDA trials are high interest news stories with lots of coverage. Two Dimebon studies are currently in progress or being planned. For those interested in learning more about how to participate in one of these studies, detail links are below.

The selection criteria and additional details for the CONNECTION study are published at the Medivation website.

Information about the forthcoming CONCERT study, a combination therapy approach including Aricept, is available at a special "CONCERT study" website where information will be published as it becomes available.